JUN 27, 2019 10:55 PM PDT

The University of Maryland to Launch a Graduate Degree in Cannabis

WRITTEN BY: C Reardon

Photo Source: University of Maryland

The University of Maryland plans to be the first university in the United States to offer a Master of Science (MS) in Medical Cannabis Science and Therapeutics. This two-year program will teach students how to treat patients medically with marijuana as well as allow students to participate in research with the intent of shaping future policy around medical cannabis.


With medical marijuana legalized in 33 states, the need for educated individuals trained in the science, and therapeutic effects, of this drug is becoming more and more apparent. This degree is all-encompassing, catering to anyone wanting to work within the medical cannabis space, whether that be future health care professionals, growers, or other industry professionals.


 "There is truly no other educational program that offers the in-depth instruction on the science, policy, and therapeutics of medical cannabis that students who are accepted into our program will receive," states Leah Sera, PharmD, MA, director of the MS in Medical Cannabis Science and Therapeutics program. The actual program is designed for students who may not have a background in science or medicine, and the only degree requirement is a completed bachelor's degree of any disciplinary. 


The course will be held mainly online, except an in-person symposium each semester. These in-person opportunities will allow students to network and interact with peers and experts in the field. The university embraced the online format in hopes that it would allow for working individuals and those who can't relocate to still participate in the degree program. 


"Students who complete our program will have an unparalleled competitive advantage when it comes to pursuing or advancing a career in the medical cannabis industry," promises Sera. "These individuals will be well-prepared to support patients and the medical cannabis industry with the knowledge and skills gained from their coursework."
 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
OCT 04, 2020
Microbiology
A Virus Can Disrupt a Carb-Consuming Gut Microbe
OCT 04, 2020
A Virus Can Disrupt a Carb-Consuming Gut Microbe
Not all viruses affect animal cells; some viruses can infect bacteria. Humans are known to carry vast numbers of microor ...
OCT 07, 2020
Neuroscience
Researchers Discover Molecular Mechanism for Memory Formation
OCT 07, 2020
Researchers Discover Molecular Mechanism for Memory Formation
Researchers from MIT have found that when the brain forms a new memory, neurons known as 'engram cells' encode t ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
OCT 15, 2020
Genetics & Genomics
Gene Variants Influence Aging and Mobility in the Elderly
OCT 15, 2020
Gene Variants Influence Aging and Mobility in the Elderly
Small changes in a gene that is involved in controlling the levels of the neurotransmitter dopamine could influence how ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
Loading Comments...